Home › Funds › NUANCE INVESTMENTS, LLC › DGX
NUANCE INVESTMENTS, LLC position in DGX
QUEST DIAGNOSTICS INC · Health Care
NUANCE INVESTMENTS, LLC reported holding 22,784 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$5.3M, representing 0.98% of its reported portfolio and ranking #29 among its reported holdings. NUANCE INVESTMENTS, LLC has disclosed DGX holdings in 7 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NUANCE INVESTMENTS, LLC's DGX position evolved
NUANCE INVESTMENTS, LLC first disclosed a stake in DGX in Q4 2023 at 602,484 shares (US$83.1M). The position peaked in Q1 2024 at 681,636 shares, worth US$90.7M. Across 7 filings, NUANCE INVESTMENTS, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 22,784 shares valued at US$5.3M — a reduction of -4,686 shares quarter over quarter.. Notable position changes include a 84% increase in Q4 2025 (shares rose 13% over the following quarter), a 56% trim in Q1 2026 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 602.48K | $83.07M | New |
| Q1 2024 | 681.64K | $90.73M | Add |
| Q3 2025 | 30.21K | $5.76M | New |
| Q4 2025 | 55.56K | $9.64M | Add |
| Q1 2026 | 24.54K | $4.81M | Reduce |
| Q2 2026 | 27.47K | $5.82M | Add |
| Q3 2026 | 22.78K | $5.31M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DGX and 13F data
DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 26 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.08B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$449.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DGX
- Boston Partners 4.64M sh · $1.08B · Q3 2026
- EdgePoint Investment Group Inc. 2.25M sh · $476.37M · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 1.93M sh · $449.89M · Q3 2026
- DAVIS SELECTED ADVISERS 1.33M sh · $308.97M · Q3 2026
- M&G Plc 770.10K sh · $179.43M · Q3 2026
More on NUANCE INVESTMENTS, LLC
FAQ
How long has NUANCE INVESTMENTS, LLC held DGX?
NUANCE INVESTMENTS, LLC has disclosed DGX holdings in 7 of the last 12 reported quarters, going back to Q4 2023.
What is NUANCE INVESTMENTS, LLC's current position in DGX?
As of Q3 2026, NUANCE INVESTMENTS, LLC holds 22.78K shares of DGX (QUEST DIAGNOSTICS INC), valued at $5.31M, representing 0.98% of its reported portfolio and ranking #29.
Has NUANCE INVESTMENTS, LLC been buying or selling DGX?
In the latest 13F filing (Q3 2026), NUANCE INVESTMENTS, LLC reduced its position in DGX. The position peaked in Q1 2024 at 681.64K shares.
Which other funds hold DGX?
Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.